Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024

World Top 100 Pharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as pf Jan-05-2024.

Metatag Title
World Top Pharmaceutical Companies in 2024
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2024, World Largest Pharmaceutical Companies by Market Cap in 2024.
  1. Boya Bio-Pharmaceutical Group

    World Rank (Jan-05-2024)
    5,216
    Market Cap (Jan-05-2024)
    2.312 Billion USD
    World Rank (Jul-30-2023)
    5,134
    Market Cap (Jul-30-2023)
    2.374 Billion USD
    World Rank (Dec-25-2022)
    4,676
    Market Cap (Dec-25-2022)
    2.490 Billion USD
    World Rank (Jan-07-2022)
    4,915
    Market Cap (Jan-07-2022)
    2.95 Billion USD
    Annual Revenue in USD
    386 Million USD
    Annual Net Income in USD
    50 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  2. Piramal Pharma Limited

    World Rank (Jan-05-2024)
    5,221
    Market Cap (Jan-05-2024)
    2.309 Billion USD
    World Rank (Jul-30-2023)
    6,777
    Market Cap (Jul-30-2023)
    1.536 Billion USD
    World Rank (Dec-25-2022)
    6,142
    Market Cap (Dec-25-2022)
    1.651 Billion USD
    Headquarters Country
    Company Profile

    Piramal Group is a global business conglomerate with diverse interests in pharma, financial services and real estate. The Group has offices in over 30 countries and a global brand presence in more than 100 markets, and operates with over 10,000 people worldwide from 21 diverse nationalities. Headquarters is in India.

  3. Sanofi India

    World Rank (Jan-05-2024)
    5,223
    Market Cap (Jan-05-2024)
    2.309 Billion USD
    World Rank (Jul-30-2023)
    5,866
    Market Cap (Jul-30-2023)
    1.942 Billion USD
    World Rank (Dec-25-2022)
    6,235
    Market Cap (Dec-25-2022)
    1.617 Billion USD
    World Rank (Jan-07-2022)
    5,700
    Market Cap (Jan-07-2022)
    2.32 Billion USD
    Annual Revenue in USD
    366 Million USD
    Annual Net Income in USD
    118 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Pharmaceutical company with headquarters is in Mumbai, India.
  4. Hisamitsu Pharmaceutical

    World Rank (Jan-05-2024)
    5,240
    Market Cap (Jan-05-2024)
    2.294 Billion USD
    World Rank (Jul-30-2023)
    4,982
    Market Cap (Jul-30-2023)
    2.473 Billion USD
    World Rank (Dec-25-2022)
    5,003
    Market Cap (Dec-25-2022)
    2.276 Billion USD
    World Rank (Jan-07-2022)
    4,998
    Market Cap (Jan-07-2022)
    2.87 Billion USD
    Annual Revenue in USD
    877 Million USD
    Annual Net Income in USD
    70 Million USD
    Annual Results for Period Ending
    Feb-2022 ending year
    Headquarters Country
    Company Profile
    Hisamitsu Pharmaceutical engages in the Research, Development, Manufacture and Sale of Pharmaceuticals and Related Products company. The company annual revenue is 140.9 billion JPY, annual net income is 18.6 billion JPY, annual operating income is 22.7 billion JPY, total assets is 307.4 billion JPY, total liabilities is 56.6 billion JPY, total equity is 249.2 billion JPY as on 2020. The headquarters is in Japan.
  5. Suven Pharmaceuticals Limited

    World Rank (Jan-05-2024)
    5,267
    Market Cap (Jan-05-2024)
    2.275 Billion USD
    World Rank (Jul-30-2023)
    6,795
    Market Cap (Jul-30-2023)
    1.530 Billion USD
    World Rank (Dec-25-2022)
    6,465
    Market Cap (Dec-25-2022)
    1.532 Billion USD
    World Rank (Jan-07-2022)
    7,087
    Market Cap (Jan-07-2022)
    1.64 Billion USD
    Annual Revenue in USD
    161 Million USD
    Annual Net Income in USD
    57 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Company Profile
    Suven Pharmaceuticals Limited is a global medical needs company focused on the business of Pharmaceuticals and Fine Chemical Intermediates for Global Pharma Companies for New Chemical Entities (NCE's) as the thrust area. The company annual revenues was 13,202 million INR and annual net income was 4,538 million INR for year ending March-2022. The headquarters is in India.
  6. KPC Pharmaceuticals

    World Rank (Jan-05-2024)
    5,278
    Market Cap (Jan-05-2024)
    2.266 Billion USD
    World Rank (Jul-30-2023)
    5,737
    Market Cap (Jul-30-2023)
    2.005 Billion USD
    World Rank (Dec-25-2022)
    6,561
    Market Cap (Dec-25-2022)
    1.498 Billion USD
    World Rank (Jan-07-2022)
    8,078
    Market Cap (Jan-07-2022)
    1.31 Billion USD
    Headquarters Country
  7. Momenta Pharmaceuticals

    World Rank (Jan-05-2024)
    5,297
    World Rank (Jul-30-2023)
    5,297
    World Rank (Dec-25-2022)
    5,297
    World Rank (Jan-07-2022)
    5,297
    Headquarters Country
    Company Profile

    Momenta Pharmaceuticals is a Biotechnology company. The headquarters is in USA.

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD.

    Facts About Company

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD

  8. Bora Pharmaceuticals

    World Rank (Jan-05-2024)
    5,385
    Market Cap (Jan-05-2024)
    2.185 Billion USD
    World Rank (Jul-30-2023)
    5,383
    Market Cap (Jul-30-2023)
    2.211 Billion USD
    World Rank (Dec-25-2022)
    8,391
    Market Cap (Dec-25-2022)
    0.993 Billion USD
    World Rank (Jan-07-2022)
    14,523
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country
  9. Portola Pharmaceuticals

    World Rank (Jan-05-2024)
    5,432
    World Rank (Jul-30-2023)
    5,432
    World Rank (Dec-25-2022)
    5,432
    World Rank (Jan-07-2022)
    5,432
    Headquarters Country
    Company Profile

    Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder.

  10. Aphria

    World Rank (Jan-05-2024)
    5,459
    World Rank (Jul-30-2023)
    5,459
    World Rank (Dec-25-2022)
    5,459
    World Rank (Jan-07-2022)
    5,459
    Headquarters Country
    Company Profile
    Aphria is a Canadian Cannabis company. It has a market capitalization of $1.2 billion as of January 2020. The headquarters is in Canada.

Share

Ads